Valuation (24%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.22 | 26.98 |
| PEG Ratio (TTM) | -0.45 | 1.77 |
| P/S Ratio (TTM) | 0.09 | 2.10 |
| P/B Ratio (TTM) | 0.07 | 1.07 |
| P/FCF Ratio (TTM) | -0.22 | 13.54 |
| Price to 5YR AVG Earnings Ratio | N/A | 10.83 |
| Price to 5YR AVG FCF Ratio | N/A | 22.86 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -8.36% | 5.72% |
| ROE (TTM) | -29.40% | 8.54% |
| Net Profit Margin (TTM) | -7.76% | 6.25% |
| ROIC 5YR AVG | N/A | 8.74% |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -23.91% | -4.09% | N/A |
| Revenue | 13.58% | 61.57% | N/A |
| Net Income | -9.75% | -4.06% | N/A |
| Cash Flow | 16.67% | -110.06% | N/A |
Health (21%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.99 | 1.58 |
| Quick Ratio (TTM) | 0.80 | 0.95 |
| D/E Ratio (TTM) | 1.99 | 0.69 |
| Interest Coverage (TTM) | -5.17 | 14.70 |
| Piotroski F-Score | 2 | 7 |
| Altman Z-Score | 0.56 | 3.30 |
| LTL to 5YR AVG FCF | N/A | 6.81 |
| Shares Outstanding Growth 5YR AVG | N/A | 2.08% |